Ferric maltol
- TRADE NAME: Accrufer (Shield Therapeutics)
- INDICATIONS: Treatment of iron deficiency in adults.
- SYNONYM: Accrufer
- CLASS: Iron supplement
- HALF-LIFE: n/a
FDA APPROVAL DATE: 07/25/2019
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:An overdose of iron in pregnant women may carry a risk for spontaneous abortion, gestational diabetes and fetal malformation.
Please login to see the rest of this drug profile
GASTROINTESTINAL/HEPATIC.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric